These findings not only confirmed the presence of widespread metastatic disease despite comparatively low PSA level, but also excluded potential differential diagnoses, including primary bladder carcinoma with prostate involvement or the coexistence of synchronous malignancies from different organ origins. This evidence concerns the gene KLK3 and metastatic neoplasm.